With President Donald Trump expected to deliver a drug pricing order on Monday that Big Pharma and patient groups alike have ...

President Donald Trump says he’ll sign an executive order on Monday intended to lower the cost of drugs in the U.S.

Deutsche Bank AG boosted its stake in Regeneron Pharmaceuticals by nearly 22% in Q4, now holding 539,269 shares valued at ...

Cantor Fitzgerald gave Regeneron a financial pick-me-up by nudging its 2025 EPS forecast to $26.88 from $26.38. This slight ...

Regeneron Pharmaceuticals recently reported earnings for Q1 2025 with a revenue drop to $3,029 million compared to the prior year, though net income increased, reflecting robust profitability with ...

Fintel reports that on May 7, 2025, Leerink Partners upgraded their outlook for Amylyx Pharmaceuticals (NasdaqGS:AMLX) from Market Perform to Outperform. As of May 7, 2025, the average one-year ...

We recently published a list of 10 Worst Blue Chip Stocks to Buy. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against other worst ...

How Does Regeneron Pharmaceuticals P/E Compare to Other Companies? The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's ...